CURRENT EYE RESEARCH, cilt.40, sa.1, ss.48-55, 2015 (SCI-Expanded)
Background: To evaluate the effects of sub-conjunctivally applied interleukin-6 receptor (IL-6R) antibody (tocilizumab) on alkali burn induced corneal neovascularization (CNV) in rats.